Acro Biomedical Co., Ltd.
ACBM
$0.0007
-$0.1043-99.33%
OTC PK
| 03/31/2024 | 03/31/2024 | 03/31/2024 | 12/31/2023 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 37.91% | 37.91% | 37.91% | 98.85% | 98.85% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 25.00% | 25.00% | 25.00% | -99.95% | -99.95% |
| Change in Net Operating Assets | -166.67% | -166.67% | -166.67% | -94.53% | -94.53% |
| Cash from Operations | -7.14% | -7.14% | -7.14% | -2,620.00% | -2,620.00% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 37.11% | 37.11% | 37.11% | 9,600.00% | 9,600.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 37.11% | 37.11% | 37.11% | 9,600.00% | 9,600.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 93.10% | 93.10% | 93.10% | -583.33% | -583.33% |